A novel test that measures proteins from nerve damage that are deposited in blood and spinal fluid reveals the rate of progression of amyotrophic lateral sclerosis (ALS) in patients, according to researchers from Mayo Clinic's campus in Florida, Emory University and the University of Florida. Their study, which appears online in the Journal of Neurology, Neurosurgery & Psychiatry, suggests this test, if perfected, could help physicians and researchers identify those patients at most risk for rapid progression... (Source: Health News from Medical News Today)
via Original Article
MedWorm Sponsor Message: Have a look at The Psychiatry Daily, the new psychiatry portal powered by MedWorm, with all the latest psychiatry news and research updated daily.
via Original Article
No comments:
Post a Comment